Canuevo Biotech

Canuevo Biotech Overview

Founded 2017
Status Private
Latest Deal Type Accelerator/​Inc
Latest Deal Amount $100K
Latest Deal Amount
Investors 1

Canuevo Biotech General Information


Developer of a drug development technology created to increase delivery efficacy. The company's drug delivery mechanisms for cannabinoid formulations improve delivery mechanisms for cannabinoids, it is making functionalized micro-encapsulations as a delivery vehicle for cannabinoids in medicine and health, enabling patients to get the medicine for their needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 48 Lamson Court
  • Fredericton, New Brunswick
  • Canada
+1 (506) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Canuevo Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 10-May-2017 $100K 00000 Completed Startup

Canuevo Biotech Executive Team (2)

Name Title Board Seat Contact Info
Nils Rehmann Ph.D Chief Executive Officer & Founder
Daniel Carbo Chief Scientific Officer

Canuevo Biotech Investors (1)

To view Canuevo Biotech‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
RebelBio Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial